Filana Therapeutics adopts 2018 Omnibus Incentive Plan Amendment No. 2

Filana Therapeutics filed an amended 2018 Omnibus Incentive Plan governing stock options, restricted stock, and other equity awards for employees, directors, and consultants. The plan amendment reflects updates to compensation structure and governance terms for talent retention and incentive alignment.